Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Translational Lung Cancer Research|November 19, 2020
Epithelial-to-mesenchymal transition is a resistance mechanism to sequential MET-TKI treatment of <i>MET</i>-amplified EGFR-TKI resistant non-small cell lung cancer cellsMichelle Simone Clement, Kristine Raaby Gammelgaard, Anders Lade Nielsen, et al.
Lung Cancer (Amsterdam, Netherlands)|May 18, 2019
Cause-and-Effect relationship between FGFR1 expression and epithelial-mesenchymal transition in EGFR-mutated non-small cell lung cancer cellsJohan Vad-Nielsen, Kristine Raaby Gammelgaard, Tina Fuglsang Daugaard, et al.
Frontiers in Immunology|February 27, 2025
IFNλ1 is a STING-dependent mediator of DNA damage and induces immune activation in lung cancerStine Høvring Godsk, Caroline Maren Stengaard Jensen, Trine Vilsbøll Larsen, et al.
Translational Lung Cancer Research|February 11, 2021
cGAS-STING pathway expression as a prognostic tool in NSCLCKristine Raaby Gammelgaard, Birgitte Sandfeld-Paulsen, Stine Høvring Godsk, et al.
Cancers|June 4, 2020
Inflammatory Cytokines and ctDNA Are Biomarkers for Progression in Advanced-Stage Melanoma Patients Receiving Checkpoint InhibitorsJesper Geert Pedersen, Anne Tranberg Madsen, Kristine Raaby Gammelgaard, et al.
Translational Oncology|December 19, 2018
Up-Regulated FGFR1 Expression as a Mediator of Intrinsic TKI Resistance in EGFR-Mutated NSCLCKristine Raaby Gammelgaard, Johan Vad-Nielsen, Michelle Simone Clement, et al.
Pageof 1